home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post navigation
Previous Post
Previous
PMV Pharmaceuticals to Present PC14586 Phase 1 Clinical Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Next Post
Next
Arvinas to Present at Bank of America Securities 2022 Healthcare Conference